News

Discover our journey to transform the treatment of cancer with precision radioligand therapies.

Mariana Oncology, a Novartis Company, Announces $50M Expansion of Radioligand Therapy R&D Facilities

Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer